Intravenous Infusions Plc reported unaudited earnings results for the six months ended June 30, 2018. For the period, the company reported revenue of GHS 10,051,384 against GHS 6,316,853 a year ago. Operating profit was GHS 2,517,221 against GHS 1,522,056 a year ago. Profit before finance cost and tax was GHS 2,517,221 against GHS 1,522,056 a year ago. Profit before tax was GHS 2,251,330 against GHS 1,110,934 a year ago. Profit for the period was GHS 1,829,206 or GHS 0.00807 per share against GHS 902,634 or GHS 0.00398 per share a year ago. Net cash from operating activities was GHS 323,599 against GHS 546,186 a year ago. Purchases of equipment was GHS 290,291 against GHS 253,858 a year ago.